Co-enrol

Studies eligible for co-enrolment with FLO-ELA:

• PREVENTT Trial

A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose with placebo in patients with anaemia undergoing major open abdominal surgery.
ISRCTN: 67322816

• PRISM Trial

An international, multi-centre, pragmatic, randomised controlled trial with open study group allocation, to determine if routine continuous positive airway pressure (CPAP) for four hours immediately after major abdominal surgery is effective prophylaxis against postoperative pneumonia, re-intubation or death.
ISRCTN: 56012545

• REST Trial

A pragmatic randomised controlled trial to determine whether Extracorporeal Carbon Dioxide Removal (VV-ECCO2R) and lower tidal volume mechanical ventilation in patients with hypoxaemic respiratory failure improves 90 day mortality.
ClinicalTrials.gov Identifier: NCT02654327

• PEPTIC

A large, multi-centre, cluster cross over, randomised registry trial comparing the safety and efficacy of proton pump inhibitors with histamine-2 receptor blockers for ulcer prophylaxis in intensive care patients.

• PQIP

Improving perioperative care through the use of quality data: Patient Study of the Perioperative Quality Improvement Programme.


Studies NOT eligible for co-enrolment with FLO-ELA:

• OPTIMISE II Trial

An international, multi-centre, pragmatic, randomised controlled trial with an open study group allocation, to determine whether cardiac output-guided fluid therapy, with a low dose inotrope infusion is clinically effective when compared to usual care in patients undergoing major gastrointestinal surgery.
ISRCTN: 39653756

• 65 Trial

Evaluating the clinical and cost effectiveness of using a more conservative mean arterial pressure target range to guide careful titration of vasopressors to minimise dose and duration in older critically ill patients with vasodilatory hypotension: the 65 trial.
ISRCTN: 10580502